From: PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients
 | Grade II | Grade III | Grade IV | P | P II v. III |
---|---|---|---|---|---|
Overall | 20.6 ± 10.6 (137) | 32.4 ± 34.3 (144) | 57.3 ± 19.9 (261) | <0.0001 |  |
IDH1/IDH2 | 21.1 ± 10.1 (127) | 26.7 ± 12.1 (102) | 52 ± 22.1 (13) | <0.0001 | 0.00023 |
CIC/FUBP1 | 21.9 ± 10.3 (37) | 28 ± 10.7 (26) |  | 0.030 |  |
LOH 1p19q | 21.7 ± 10.1 (42) | 28.2 ± 10.2 (32) |  | 0.0081 |  |
ATRX | 21.6 ± 10.3 (67) | 26 ± 11.2 (51) | 65.4 ± 40.1 (14) | <0.0001 | 0.034 |
TP53 | 21.4 ± 10.2 (71) | 33 ± 46.1 (74) | 60.5 ± 23 (78) | <0.0001 | 0.038 |
EGFR |  | 41.9 ± 12.7 (15) | 60.3 ± 16.6 (69) | <0.0001 |  |
PTEN |  | 42.8 ± 10.8 (12) | 62.7 ± 21.3 (80) | <0.0001 |  |
alt 7/10 | 24 ± 10.6 (3) | 43.5 ± 10.1 (26) | 59.6 ± 16.7 (185) | <0.0001 |  |
NF1 | 12 ± 7.2 (3) | 57.6 ± 101.6 (14) | 56.6 ± 15.5 (27) | 0.97 |  |